Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,587 recruiting studies in this area right now.
By phase
- Not applicable9,776
- Phase 24,446
- Phase 12,737
- Phase 1/Phase 21,691
- Phase 31,394
- Phase 2/Phase 3280
- Phase 4263
Top conditions
- Breast Cancer1,226
- Cancer660
- Prostate Cancer651
- Colorectal Cancer494
- Lung Cancer425
- Ovarian Cancer340
- Multiple Myeloma332
- Gastric Cancer298
- Acute Myeloid Leukemia292
- Pancreatic Cancer292
- Hepatocellular Carcinoma283
- Solid Tumor256
- Advanced Solid Tumor255
- Cervical Cancer232
- Head and Neck Cancer226
- Endometrial Cancer206
- Advanced Solid Tumors192
- Bladder Cancer192
Leading sponsors
- M.D. Anderson Cancer Center451
- Fudan University312
- Sun Yat-sen University291
- Memorial Sloan Kettering Cancer Center289
- National Cancer Institute (NCI)287
- Mayo Clinic242
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences151
- City of Hope Medical Center148
- AstraZeneca133
- University Health Network, Toronto125
Where studies are running
- California1,428
- Texas638
- Arizona513
- Florida448
- Alabama421
- New York407
- Massachusetts342
- Maryland329
- New Jersey267
- Pennsylvania245
Recruiting studies20,587 total
- NCT06576115RecruitingPhase 2
Combination therapy with device for metastatic pancreatic cancer
This trial tests whether adding a non-invasive device that uses low-level radio waves to standard chemotherapy (gemcitabine and nab-paclitaxel) can help people with pancreatic cancer that has spread to other parts of the body.
Clarkston, MichiganAges 18 years+ - NCT06525740RecruitingPhase 4
Comparing two pain medicines for gynecologic cancer surgery
This trial compares two different pain medicines (methadone given by mouth or IV vs. hydromorphone given through a spinal injection) after surgery for gynecologic cancer. It aims to find which option provides better pain relief with fewer side effects.
Rochester, MinnesotaAges Any age - NCT06572319RecruitingPhase 1/Phase 2
Combination drug trial for HER2-positive stomach cancer
This trial tests two drugs, disitamab vedotin and trastuzumab, for people with HER2-positive stomach or gastroesophageal junction cancer that has spread or come back after at least one prior treatment. The goal is to see if this combination can help shrink tumors.
Hangzhou, ZhejiangAges 18–75 - NCT06517355Recruiting
Onco-sexology program for laryngectomy patients and partners
This study tests an onco-sexology program designed to help patients who have had their voice box removed (laryngectomy) and their partners improve their intimate life and well-being after cancer treatment.
ToulouseAges 18 years+ - NCT06565260Recruiting
Exercise and nutrition program for cancer survivors and caregivers
This study offers a community-based program of exercise and nutrition classes for cancer survivors and their caregivers. It aims to help improve health and well-being after cancer treatment.
Buffalo, New YorkAges 18 years+ - NCT06546592Recruiting
AI tool for better breast radiation planning
This trial tests whether an artificial intelligence (AI) tool can help doctors plan radiation therapy more precisely for breast cancer. It aims to make treatment safer and more effective by using AI to outline the area to be treated.
Dubbo, New South WalesAges 18 years+ - NCT06548529Recruiting
HER2 PET/CT scan to predict treatment response in bladder cancer
This trial uses a special PET/CT scan to see if your bladder cancer has HER2 proteins, which can help predict how well you will respond to a targeted antibody-drug conjugate treatment. It is for people with advanced bladder cancer who have already tried certain standard therapies.
BeijingAges 18–80 - NCT06563245RecruitingPhase 2/Phase 3
Brentuximab vedotin for Hodgkin lymphoma in children and young adults
This trial tests the drug brentuximab vedotin for children and young adults (ages 2 to under 35) who have just been diagnosed with classical Hodgkin lymphoma. The treatment is guided by PET/CT scans to see how well it works.
ShanghaiAges 2–35 - NCT06572514RecruitingPhase 1/Phase 2
Lower radiation after chemo-immunotherapy for head and neck cancer
This trial tests if giving less radiation than usual is safe and effective for certain head and neck cancers after initial treatment with chemotherapy and immunotherapy. It aims to reduce side effects while still controlling the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06928584RecruitingPhase 2
Shorter Radiation Plus Immunotherapy for Recurrent Rectal Cancer
This trial tests whether a shorter, higher-dose radiation course (hypofractionated) combined with immunotherapy works better than standard radiation for locally recurrent rectal cancer that hasn't spread elsewhere. It's for people who haven't had chemotherapy or recent pelvic radiation.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06541158Recruiting
Help with transportation for cancer treatment
This study tests a tool to help patients with solid tumors who are getting radiation therapy overcome transportation problems. If you have trouble getting to appointments, this could help you find ways to get there more easily.
Atlanta, GeorgiaAges 18 years+ - NCT06977737RecruitingPhase 1/Phase 2
Study of ATTR-01 for certain solid tumors
This trial tests a new treatment called ATTR-01 for people with certain types of solid tumors that have a specific protein (αvβ6 integrin) in high amounts. It is for those who have already tried standard treatments and need new options.
BarcelonaAges 18 years+ - NCT06551116Recruiting
Better HER2 testing for HER2-low breast cancer on Enhertu
This study looks at using a more detailed lab test to measure HER2 levels in people with HER2-low metastatic breast cancer who are starting or have just started treatment with Enhertu. The goal is to see if this test can help doctors better understand who might benefit from Enhertu.
San Francisco, CaliforniaAges 18 years+ - NCT06524583RecruitingPhase 2
Chemotherapy after surgery for high-risk uterine leiomyosarcoma
This trial tests whether chemotherapy after surgery can help prevent uterine leiomyosarcoma from coming back in patients who are at high risk based on a genetic test of their tumor. It is for women with early-stage cancer (stage I) who have had complete surgery.
AngersAges 18–75 - NCT06534814Recruiting
AI tool to find lymph node spread in gastric cancer
This trial is testing a new artificial intelligence (AI) model to help doctors better identify whether gastric cancer has spread to nearby lymph nodes. If you qualify, you may help improve how this cancer is diagnosed and treated, without any extra invasive procedures.
Shijiazhuang, HebeiAges 18 years+ - NCT06562777Recruiting
How symptoms differ between men and women during immunotherapy
This study looks at how symptoms during immunotherapy (a cancer treatment that boosts your immune system) may differ between men and women. Researchers will follow people with cancer who are starting immunotherapy to see if men and women report different side effects.
Portland, OregonAges 18 years+ - NCT06761417RecruitingPhase 2
Liposomal mitoxantrone for children and young adults with relapsed solid tumors
This trial tests a new form of chemotherapy (liposomal mitoxantrone) for children, adolescents, and young adults whose solid tumors have come back or not responded to treatment. The goal is to see if this combination regimen can help shrink tumors.
BeijingAges 6–24 - NCT06518135Recruiting
Sentinel node biopsy after chemo for initial node-positive breast cancer
This trial checks whether a less invasive sentinel lymph node biopsy (removing just a few nodes) can safely replace full lymph node removal for people whose breast cancer and underarm lymph nodes responded well to chemotherapy. It is for patients who initially had 1 to 3 involved nodes and now appear cancer-free in the armpit.
Henan, HenanAges 18–70 - NCT06534125Recruiting
Acupuncture to prevent joint pain from hormone therapy in Black women
This study tests whether acupuncture can prevent joint pain caused by a common hormone therapy pill (aromatase inhibitor) in Black women who have finished treatment for early-stage breast cancer.
Atlanta, GeorgiaAges 18 years+ - NCT06556550RecruitingPhase 2/Phase 3
Targeted radiation for limited cancer spread vs. standard care
This trial tests whether high-precision radiation (SBRT) can improve outcomes for people with up to 5 small, stable metastases from certain cancers, compared to usual palliative care. It is for those whose disease is not growing after current chemotherapy.
Obninsk, Kaluga OblastAges 18 years+ - NCT06524843Recruiting
Evaluating fracture risk from cancer spread to bone
This study looks at people with cancer that has spread to the bones. It uses your medical imaging and records to understand your risk of bone fracture, without testing any new treatment.
Bologna, Emilia-RomagnaAges 18 years+ - NCT06554899Recruiting
Helping patients manage fear of cancer returning
This trial is testing a program led by a clinician (like a doctor or nurse) to help people who are worried about their cancer returning. It's for people who recently finished treatment for breast, ovarian, prostate, or lung cancer.
AarhusAges 18 years+ - NCT06535867Recruiting
Comparing phone-based vs. in-person mouth cancer screening in rural India
This study compares two ways to find early signs of mouth cancer or conditions that could lead to cancer. One method uses a simple phone-based health check, and the other uses standard in-person screening. People in rural areas of Varanasi who are at risk—such as those who use tobacco or have mouth sores—may be able to join.
New York, New YorkAges 18 years+ - NCT06568679Recruiting
Improving detection and treatment of early-onset colorectal cancer
This study aims to find better ways to detect and treat colorectal cancer in younger adults (ages 18–49). It includes people with both early-stage and advanced cancer.
Amsterdam, North HollandAges 18–49
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,587 recruiting oncology studies from the U.S. registry right now, out of 31,171 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.